Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
Nuclear Medicine
CHOLINE
Name:
Oncopet Radiofarma®
Active Principle:
18F-Fluorocholine
Therapeutic Action:
It is indicated for the initial staging of prostate cancer as well as local regional or metastatic recurrences in the case of an increase in PSA.
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut...

